A Biomimetic C-Terminal Extension Strategy for Photocaging Amidated Neuropeptides.
Journal
Journal of the American Chemical Society
ISSN: 1520-5126
Titre abrégé: J Am Chem Soc
Pays: United States
ID NLM: 7503056
Informations de publication
Date de publication:
13 09 2023
13 09 2023
Historique:
medline:
14
9
2023
pubmed:
31
8
2023
entrez:
31
8
2023
Statut:
ppublish
Résumé
Photoactivatable neuropeptides offer a robust stimulus-response relationship that can drive mechanistic studies into the physiological mechanisms of neuropeptidergic transmission. The majority of neuropeptides contain a C-terminal amide, which offers a potentially general site for installation of a C-terminal caging group. Here, we report a biomimetic caging strategy in which the neuropeptide C-terminus is extended via a photocleavable amino acid to mimic the proneuropeptides found in large dense-core vesicles. We explored this approach with four prominent neuropeptides: gastrin-releasing peptide (GRP), oxytocin (OT), substance P (SP), and cholecystokinin (CCK). C-terminus extension greatly reduced the activity of all four peptides at heterologously expressed receptors. In cell type-specific electrophysiological recordings from acute brain slices, subsecond flashes of ultraviolet light produced rapidly activating membrane currents via activation of endogenous G protein-coupled receptors. Subsequent mechanistic studies with caged CCK revealed a role for extracellular proteases in shaping the temporal dynamics of CCK signaling, and a striking switch-like, cell-autonomous anti-opioid effect of transient CCK signaling in hippocampal parvalbumin interneurons. These results suggest that C-terminus extension with a photocleavable linker may be a general strategy for photocaging amidated neuropeptides and demonstrate how photocaged neuropeptides can provide mechanistic insights into neuropeptide signaling that are inaccessible using conventional approaches.
Identifiants
pubmed: 37649440
doi: 10.1021/jacs.3c03913
pmc: PMC10510324
doi:
Substances chimiques
Neuropeptides
0
Amides
0
Amino Acids
0
Analgesics, Opioid
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
19611-19621Subventions
Organisme : NIGMS NIH HHS
ID : R35 GM133802
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS113295
Pays : United States
Organisme : NINDS NIH HHS
ID : T32 NS007220
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007240
Pays : United States
Références
FASEB J. 1989 Feb;3(2):145-51
pubmed: 2521610
Angew Chem Int Ed Engl. 2022 Aug 22;61(34):e202206122
pubmed: 35723610
Molecules. 2021 Dec 30;27(1):
pubmed: 35011444
Science. 1992 May 8;256(5058):830-3
pubmed: 1589765
Proc Natl Acad Sci U S A. 2023 Feb 7;120(6):e2216230120
pubmed: 36724251
J Med Chem. 1966 Jan;9(1):55-7
pubmed: 6006226
Mol Pharmacol. 2018 Apr;93(4):323-334
pubmed: 29367257
Trends Neurosci. 2022 Dec;45(12):899-912
pubmed: 36257845
Nat Commun. 2022 Feb 14;13(1):853
pubmed: 35165283
Mol Pharmacol. 2000 Dec;58(6):1570-80
pubmed: 11093798
Nat Methods. 2023 May;20(5):682-685
pubmed: 36973548
Elife. 2019 Nov 11;8:
pubmed: 31710287
ACS Chem Neurosci. 2023 Feb 15;14(4):516-523
pubmed: 36719384
Neuron. 2019 Jul 3;103(1):102-117.e5
pubmed: 31103358
Nat Commun. 2022 Jul 18;13(1):4153
pubmed: 35851571
Mol Pharmacol. 2014 Jul;86(1):52-61
pubmed: 24748657
J Biol Chem. 1987 Dec 5;262(34):16456-60
pubmed: 2824495
J Neurosci. 1996 Aug 15;16(16):5141-53
pubmed: 8756443
Nat Commun. 2021 Feb 5;12(1):815
pubmed: 33547286
ACS Chem Neurosci. 2018 Apr 18;9(4):684-690
pubmed: 29266926
Proc Natl Acad Sci U S A. 1988 Nov;85(21):8326-30
pubmed: 3186727
Photochem Photobiol Sci. 2016 May 11;15(5):604-8
pubmed: 27050155
Nature. 2013 Aug 22;500(7463):458-62
pubmed: 23913275
Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):11025-30
pubmed: 9380753
Nat Commun. 2023 Feb 24;14(1):1066
pubmed: 36828816
Mol Pharmacol. 1981 Nov;20(3):457-9
pubmed: 6173735
Sci Adv. 2021 Dec 10;7(50):eabk2872
pubmed: 34878828
Endocrinology. 2006 Jan;147(1):502-9
pubmed: 16223866
ACS Med Chem Lett. 2019 Nov 19;11(1):16-22
pubmed: 31938457
Chem Commun (Camb). 2010 Dec 21;46(47):8935-7
pubmed: 21046030
Mol Pharmacol. 1980 Jul;18(1):78-83
pubmed: 6157980
Cell. 2021 Oct 28;184(22):5622-5634.e25
pubmed: 34610277
Science. 1983 Jan 21;219(4582):310-2
pubmed: 6294831
Philos Trans R Soc Lond B Biol Sci. 2021 Mar 29;376(1821):20190761
pubmed: 33550946
Exp Mol Med. 2018 May 21;50(5):1-16
pubmed: 29780163
J Pharmacol Exp Ther. 1987 Oct;243(1):397-401
pubmed: 3668866
Nature. 1996 Apr 4;380(6573):403-9
pubmed: 8602240
Mol Pharmacol. 2003 May;63(5):973-82
pubmed: 12695525
Nature. 1965 Sep 25;207(5004):1356-9
pubmed: 5886035
J Neurosci. 2011 Jul 27;31(30):10993-1002
pubmed: 21795548
J Neurophysiol. 2001 Jan;85(1):280-6
pubmed: 11152727
Peptides. 1995;16(4):733-40
pubmed: 7479310
Cell Chem Biol. 2022 Dec 15;29(12):1729-1738.e8
pubmed: 36481097
Neuron. 2012 Jan 26;73(2):249-59
pubmed: 22284180
Elife. 2021 Nov 17;10:
pubmed: 34787079
Bioconjug Chem. 2001 Jan-Feb;12(1):44-50
pubmed: 11170364
Neuron. 2016 Mar 16;89(6):1291-1304
pubmed: 26948889
Mol Pharmacol. 1996 Oct;50(4):885-90
pubmed: 8863834
Nat Chem Biol. 2021 Dec;17(12):1230-1237
pubmed: 34556863
Brain Res. 1999 Nov 27;848(1-2):78-89
pubmed: 10612699
Chem Commun (Camb). 2006 Apr 14;(14):1557-9
pubmed: 16575459